FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/11/2026
Back to search
Official data from USPTO
REYOHMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/11/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
02/21/2025
Registration date
02/03/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Chiyoda-ku, Tokyo, JP
Examiner
SONG, SAMUEL
Current location
Historical data usage
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
Norm J. Rich Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; immunomodulators and immunosuppressive agents being pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines being anti-emetic preparations; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; chemical reagents for medical purposes in the field of oncology
Publications
History of USPTO decisions and trademark events.
29 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/11/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/16/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/03/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/17/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/16/2025
PUBO
PUBLISHED FOR OPPOSITION
12/16/2025
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2025
RFNT
REFUSAL PROCESSED BY IB
10/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/14/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2025
RFRR
REFUSAL PROCESSED BY MPU
09/27/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/16/2025
CNRT
NON-FINAL ACTION WRITTEN
08/15/2025
DOCK
ASSIGNED TO EXAMINER
07/02/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/08/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/03/2025
Continuous trademark protection
Get notified about every new filing that threatens REYOHMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.